Tuesday April 23, 2019

Blood Test Can Help Diagnose Pre-eclampsia, Says Study

There was no change in the likelihood of complications for the baby, the age at which babies were delivered prematurely or whether they were admitted to a neonatal unit

0
//
Image source- sites.bu.edu

A simple blood test can help diagnose a common but potentially fatal pregnancy complication — pre-eclampsia, finds a study published in The Lancet journal.

During the study, by measuring the concentration of placental growth factor (PlGF) in a woman’s blood, doctors were able to diagnose pre-eclampsia two days sooner on average.

“We knew monitoring PlGF was an accurate way to help detect the condition but were unsure whether making this tool available to clinicians would lead to better care for women. Now we know that it does,” said lead author Lucy Chappell from King’s College London.

Pre-eclampsia, a condition in pregnancy characterised by high blood pressure, sometimes with fluid retention and proteinuria, can cause damage to vital organs, fits and can be fatal for the woman and baby, if left untreated. Globally, 100 women die due to pre-eclampsia every day.

A health service worker takes a blood sample for a malaria test in Dajabon, Dominican Republic, on the border with Haiti, Oct. 6, 2009. A test that doesn't require a needle or blood has won the Africa Prize for Engineering Innovation
A health service worker takes a blood sample for a malaria test in Dajabon, Dominican Republic, on the border with Haiti, Oct. 6, 2009. VOA

“For the last hundred years, we have diagnosed pre-eclampsia by measuring blood pressure and checking for protein in a woman’s urine. These are relatively imprecise and often quite subjective,” Chappell noted.

For the study, the research team studied 1,035 women with suspected pre-eclampsia from 11 maternity units across the UK. They were randomly assigned to two groups — one had their PlGF test results made available to their clinical team, the other did not.

Also Read- AI Method Can Help Treat Brain Tumours: Study

The PlGF testing was shown to reduce the average time to diagnose pre-eclampsia from four to two days and serious complications before birth (such as eclampsia, stroke, and maternal death) to four per cent from five per cent.

There was no change in the likelihood of complications for the baby, the age at which babies were delivered prematurely or whether they were admitted to a neonatal unit, the researchers said. (IANS)

Next Story

Potentially Fatal Pregnancy Can Now Be Detected By A Simple Blood Test, Claims Research

The PlGF testing was shown to reduce the average time to diagnose pre-eclampsia from four to two days and serious complications before birth (such as eclampsia, stroke, and maternal death) to four per cent from five per cent.

0
pregnancy
There was no change in the likelihood of complications for the baby, the age at which babies were delivered prematurely or whether they were admitted to a neonatal unit, the researchers said. Pixabay

A simple blood test can help diagnose a common but potentially fatal pregnancy complication — pre-eclampsia, finds a study published in The Lancet journal.

During the study, by measuring the concentration of placental growth factor (PlGF) in a woman’s blood, doctors were able to diagnose pre-eclampsia two days sooner on average.

“We knew monitoring PlGF was an accurate way to help detect the condition but were unsure whether making this tool available to clinicians would lead to better care for women. Now we know that it does,” said lead author Lucy Chappell from King’s College London.

pregnancy
For the study, the research team studied 1,035 women with suspected pre-eclampsia from 11 maternity units across the UK. They were randomly assigned to two groups — one had their PlGF test results made available to their clinical team, the other did not. Pixabay

Pre-eclampsia, a condition in pregnancy characterised by high blood pressure, sometimes with fluid retention and proteinuria, can cause damage to vital organs, fits and can be fatal for the woman and baby, if left untreated. Globally, 100 women die due to pre-eclampsia every day.

“For the last hundred years, we have diagnosed pre-eclampsia by measuring blood pressure and checking for protein in a woman’s urine. These are relatively imprecise and often quite subjective,” Chappell noted.

blood
During the study, by measuring the concentration of placental growth factor (PlGF) in a woman’s blood, doctors were able to diagnose pre-eclampsia two days sooner on average. Pixabay

For the study, the research team studied 1,035 women with suspected pre-eclampsia from 11 maternity units across the UK. They were randomly assigned to two groups — one had their PlGF test results made available to their clinical team, the other did not.

Also Read: Surrogate Mother for Son, 61 Year Old Mother Becomes The Support

The PlGF testing was shown to reduce the average time to diagnose pre-eclampsia from four to two days and serious complications before birth (such as eclampsia, stroke, and maternal death) to four per cent from five per cent.

There was no change in the likelihood of complications for the baby, the age at which babies were delivered prematurely or whether they were admitted to a neonatal unit, the researchers said. (IANS)